Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Morgan Stanley Maintains Overweight on Globe Life, Lowers Price Target to $177

Author: Benzinga Newsdesk | November 17, 2025 09:47am
Morgan Stanley analyst Bob Huang maintains Globe Life (NYSE:GL) with a Overweight and lowers the price target from $179 to $177.

Posted In: GL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist